Localized Scleroderma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Localized Scleroderma

What is the definition of Localized Scleroderma?
Localized scleroderma is characterized by thickening of the skin from excessive collagen deposits. Collagen is a protein normally present in our skin that provides structural support. However, when too much collagen is made, the skin becomes stiff and hard. Localized types of scleroderma are those limited to the skin and related tissues and, in some cases, the muscle below. Internal organs are not affected by Localized scleroderma, and Localized scleroderma can never progress to the systemic form of the disease. Often, localized conditions improve or go away on their own over time, but the skin changes and damage that occur when the disease is active can be permanent. For some people, Localized scleroderma is serious and disabling. There are two generally recognized types of Localized scleroderma: morphea and linear.
What are the alternative names for Localized Scleroderma?
  • Localized scleroderma
  • Localized fibrosing scleroderma
  • Scleroderma, localized
Who are the top Localized Scleroderma Local Doctors?
Elite in Localized Scleroderma
Dermatology
Elite in Localized Scleroderma
Dermatology
Referral may be required

Dermatology Clinic At Mount Zion

1701 Divisadero St., Third And Fourth Floors, 
San Francisco, CA 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Anna Haemel is a Dermatologist practicing medicine in San Francisco, California. Dr. Haemel is rated as an Elite provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Localized Scleroderma, Dermatomyositis, Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE). Dr. Haemel is board certified in American Board Of Dermatology, Dermatology and American Board Of Internal Medicine, Internal Medicine. Dr. Haemel is currently accepting new patients.

Elite in Localized Scleroderma
Elite in Localized Scleroderma
Referral may be required

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
Languages Spoken:
English
Accepting New Patients

Heidi Jacobe is a Dermatologist practicing medicine in Dallas, Texas. Dr. Jacobe is rated as an Elite provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Localized Scleroderma, Scleroderma, Systemic Sclerosis (SSc), and Scleroma. Dr. Jacobe is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Localized Scleroderma
Pediatric Rheumatology
Elite in Localized Scleroderma
Pediatric Rheumatology
Referral may be required

Hackensack University Medical Center

30 Prospect Avenue, Pediatric Rheumatology, Wfan, Pc 360, 
Hackensack, NJ 
Languages Spoken:
English
Accepting New Patients

Suzanne Li is a Pediatric Rheumatologist practicing medicine in Hackensack, New Jersey. Dr. Li is rated as an Elite provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Localized Scleroderma, Systemic Sclerosis (SSc), PFAPA, and Pulmonary Alveolar Proteinosis. Dr. Li is board certified in American Board Of Pediatrics. Dr. Li is currently accepting new patients.

What are the latest Localized Scleroderma Clinical Trials?
Immunologic and Genetic Profiles in Subsets of Morphea Patients

Summary: The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: * How morphea behaves over time * How frequently specific problems occur along with morphea (for example, arthritis) * Whether morphea has an autoimmune backgro...

Match to trials
Find the right clinical trials for you in under a minute
Get started
International Multicentre Cohort Study on Clinical Manifestations and Response to Therapy in Juvenile Onset Eosinophilic Fasciitis

Summary: Eosinophilic fasciitis is a connective tissue disorder characterized by inflammation of the muscle fasciae, which is very rare in children. In juvenile-onset eosinophilic fasciitis (JEF), there may be severe joint involvement and skin manifestations may be less prevalent than in adults. It represents an important differential diagnosis of both juvenile-onset systemic sclerosis and localized sclero...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center